Dr Irwin Lim _connectedcare
Hand OA responds to 10mg/d Pred over 6wks. As expected symptoms return on cessation Anecdotally, there are people who do well on pragmatic, long term low dose eg 5mg or less/d #ACR19 @rheumnow Abst1760 https://t.co/FtE9vHb655
Dr. John Cush RheumNow
#ACR19 Rheumatology RoundUp - Kavanaughs Picks: 2505 PsA prevention 1366 Self Joint exams 1120 Rheum burnout 1310 OA Hx 565 Enteropathic arthritis Recs 1823 MRE dx of SI 2773 Machine learning 2772 Antiinflammatory diet in RA 1359 Synovial Bx
Dr. Lau discusses abstract #2730 presented at the 2019 ACR/ARP annual meeting in Atlanta.
Mike Putman EBRheum
#ACR19 Guidelines for OA: my take home is this truly astonishing funnel plot Virtually zero small negative studies and dozens of small positive studies Clear trend toward NO effect w/more precision in trial Publication bias et al. in action!! @RheumNow https://t.co/65nKzghobz
Dr. Deal highlights the session 'Bad to the Bone: Metabolic Bone Disease" at the 2019 ACR/ARP Annual Meeting in Atlanta.
Dr. Deal highlights The Great Debate: Anabolic Agents Are/Are Not Appropriate First-Line Therapy for Glucocorticoid-Induced Osteoporosis, and offers his opinion on this debate at the 2019 ACR/ARP Annual Meeting in Atlanta.
Dr. Rachel Tate uptoTate
OP related fracture risk projected to increase to 33% by 2030. Medicare cohort from 2010- 2014 data review suggestions worsening fracture management. https://t.co/anG80uMjEV abs#1872 #ACR19 @RheumNow
k dao KDAO2011
#acr19 @rheumnow Great debate Who won? Dr Saag (62% yes votes) But Dr Humphrey NO-anabolic stance as first line for GIO make sense for many patients; antiresorptives do work for GIO and cost per fracture prevented is so much less
Olga Petryna DrPetryna
#ACR19 @rheumnow abs1759 1-y prospective, monocentric, DB, PBO-cont stdy MTX (10mg/wk) vs PBO in erosive hand OA demonstrates no improvement in VAS pain score with MTX. at the same time MTX significantly ⬇️progression of joint damage vs PBO & seems to facilitate bone remodeling
David Liew drdavidliew
@RheumNow What about pred for hand OA? Well PNL 10 has an effect while you're taking it, with reduction of synovial thickening, and in this study was well tolerated. Stop taking it, and you're back to baseline. Leiden #ACR19 ABST 1760 @RheumNow https://t.co/aw4UNHol7J
Dr. John Cush RheumNow
RA pts have a high prevalence of osteoporosis (OP-34%) & vertebral osteoporotic Fx (VOPF-20%). OP risk with Older age, female sex, lower BMI, higher Dz activity & severity. VOPF risk driven by older age & higher GC daily dose. https://t.co/BbSmUHPrHf